85 related articles for article (PubMed ID: 2236453)
21. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
22. What constitutes an adequate antidepressant trial for fluoxetine?
Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
[TBL] [Abstract][Full Text] [Related]
23. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre LF; Putman HP
J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study].
Cabras PL; Enriques E; Casini A; Paoletti C; Zagnoni P
Minerva Psichiatr; 1991; 32(2):93-101. PubMed ID: 1870418
[TBL] [Abstract][Full Text] [Related]
25. An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patients.
Mesters P; Ansseau M; Brasseur R; Bussios G; Cosyns P; Czarka M; De Buck R; De Frenne A; Dierick M; Linkowski P
Acta Psychiatr Belg; 1992; 92(4):232-45. PubMed ID: 1345403
[TBL] [Abstract][Full Text] [Related]
26. [Bipolar disorder: clinical trials with fluoxetine].
Ambrosio LA; Buccomino D; Filippo A; Filippo P; Marchese G; Barrese E; Paoletti C; Colonna CV
Minerva Psichiatr; 1992; 33(4):305-12. PubMed ID: 1297908
[TBL] [Abstract][Full Text] [Related]
27. Anger attacks in depressed outpatients and their response to fluoxetine.
Fava M; Rosenbaum JF; McCarthy M; Pava J; Steingard R; Bless E
Psychopharmacol Bull; 1991; 27(3):275-9. PubMed ID: 1775598
[TBL] [Abstract][Full Text] [Related]
28. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
Heiligenstein JH; Tollefson GD; Faries DE
J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
[TBL] [Abstract][Full Text] [Related]
29. Mood, major depression, and fluoxetine response in cigarette smokers.
Dalack GW; Glassman AH; Rivelli S; Covey L; Stetner F
Am J Psychiatry; 1995 Mar; 152(3):398-403. PubMed ID: 7864266
[TBL] [Abstract][Full Text] [Related]
30. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
Stewart JW; Quitkin FM; McGrath PJ; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
Arch Gen Psychiatry; 1998 Apr; 55(4):334-43. PubMed ID: 9554429
[TBL] [Abstract][Full Text] [Related]
31. [Fluoxetine and depression in the elderly. Clinical experience].
Ambrosio LA; Barrese E; Bertini M; Buccomino D; Casini A; Filippo A; Filippo P; Marchese G; Paoletti C
Minerva Psichiatr; 1992; 33(3):185-94. PubMed ID: 1474882
[TBL] [Abstract][Full Text] [Related]
32. Fluoxetine in family practice patients.
Taylor AT; Wagner PJ; Pritchard DC; Tollison JW
J Fam Pract; 1994 Jul; 39(1):45-9. PubMed ID: 8027732
[TBL] [Abstract][Full Text] [Related]
33. Severity of depression and response to fluoxetine.
Pande AC; Sayler ME
Int Clin Psychopharmacol; 1993; 8(4):243-5. PubMed ID: 8277142
[TBL] [Abstract][Full Text] [Related]
34. Melatonin for the treatment of sleep disturbances in major depressive disorder.
Dolberg OT; Hirschmann S; Grunhaus L
Am J Psychiatry; 1998 Aug; 155(8):1119-21. PubMed ID: 9699707
[TBL] [Abstract][Full Text] [Related]
35. Unexpected deaths in depressed medical inpatients treated with fluoxetine.
Spier SA; Frontera MA
J Clin Psychiatry; 1991 Sep; 52(9):377-82. PubMed ID: 1894590
[TBL] [Abstract][Full Text] [Related]
36. Neurophysiologic predictors of treatment response to fluoxetine in major depression.
Cook IA; Leuchter AF; Witte E; Abrams M; Uijtdehaage SH; Stubbeman W; Rosenberg-Thompson S; Anderson-Hanley C; Dunkin JJ
Psychiatry Res; 1999 Mar; 85(3):263-73. PubMed ID: 10333379
[TBL] [Abstract][Full Text] [Related]
37. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients.
Heiligenstein JH; Faries DE; Rush AJ; Andersen JS; Pande AC; Roffwarg HP; Dunner D; Gillin JC; James SP; Lahmeyer H
Psychiatry Res; 1994 Jun; 52(3):327-39. PubMed ID: 7991725
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
Noguera R; Altuna R; Alvarez E; Ayuso JL; Casais L; Udina C
J Affect Disord; 1991 Jul; 22(3):119-24. PubMed ID: 1918655
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing.
Burke WJ; Hendricks SE; McArthur-Campbell D; Jacques D; Stull T
Psychopharmacol Bull; 1996; 32(1):27-32. PubMed ID: 8927671
[TBL] [Abstract][Full Text] [Related]
40. High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine.
Fava M; Rosenbaum JF; Cohen L; Reiter S; McCarthy M; Steingard R; Clancy K
J Affect Disord; 1992 Aug; 25(4):229-34. PubMed ID: 1430659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
